The company continues to focus on innovation and patient outcomes in the sleep apnea treatment ... rates for the Inspire 5 therapy, UBS believes the ease of the implant procedure could encourage ...

Inspire Medical Systems, Inc. ( NYSE: INSP) Q1 2025 Results Conference Call May 5, 2025 5:00 PM ET Ezgi Yagci - Vice President of Investor Relations Tim Herbert - President & Chief Executive Officer ...

Inspire Medical (TASE:BLWV) Systems, Inc. (NYSE:INSP), a medical technology company focused on treating obstructive sleep apnea (OSA), presented its latest ... including a 20% reduction in implant ...

Over the past few years, he has performed more than 100 procedures to implant a device called Inspire into people with sleep apnea who have not had success with other treatments, such as CPAP ...

offering a life-changing solution for patients with obstructive sleep apnea (OSA) who struggle with traditional CPAP therapy. Dr. Steven Landau The Inspire procedure is an advanced outpatient ...

LivaNova hopes to bring it to market to treat adult patients with moderate to severe obstructive sleep apnea (OSA). If successful, the implant could rival Inspire Medical’s neurostimulator as an ...

The company continues to focus on innovation and patient outcomes in the sleep apnea treatment market ... Despite concerns about reimbursement rates for the Inspire 5 therapy, UBS believes the ease of ...